Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 22
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/15/2007
1.
Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
14 to 75
NCI
EST-3377
2.
Phase I-II Chemotherapy with Maytansine for Solid Tumors and Hematologic Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
MDA-DT-7608
3.
Phase II Chemotherapy with Maytansine for Acute Leukemia in Children
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
21 and under
NCI
POG-7819
MDAR-324
4.
Phase II Chemotherapy with Maytansine for Refractory Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
SEG-78ST222
SEG-78ST0102
5.
Phase II Chemotherapy with Maytansine for Malignant Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
DFCI-77015
6.
Phase II Chemotherapy with Maytansine for Advanced Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
SWOG-7809
7.
Phase II Chemotherapy with Maytansine for Advanced Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
SWOG-7820
8.
Phase II Chemotherapy with Maytansine for Advanced Hodgkin's and non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
SWOG-7821
9.
Phase II Chemotherapy with Maytansine for Squamous Cell Carcinoma of the Lung
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
UMCC-7708
10.
Phase II Chemotherapy with Maytansine for Advanced Malignant Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
WSU-C-24077
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute